30-d #benznidazole is noninferior to standard 60-d tx (either benznidazole or nifurtimox) & had ⬇️drug side effects for #Chagas disease #TropMed #IDSky #TrypanosomaCruzi @thelancetinfdis.bsky.social
www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00436-6
thelancet.com
Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial
Benznidazole 150 mg once daily for 30 days showed non-inferior efficacy and the lowest
rate of drug-related adverse events among the regimens tested, supporting its adoption
as the preferred benznidaz...